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Abstract 
The tRNAHis guanylyltransferase (Thg1) is an essential, highly conserved enzyme in many 
eukaryotes, and the cytoplasmic role for members of this enzyme family has been well 
established and extensively studied; the Thg1 enzyme is well known to use an unusual 3'-5' 
polymerase activity to play an essential role in maturation of nucleus-encoded tRNAHis. 
However, recent studies in the slime mold Dictyostelium discoideum (Ddi-) have revealed new 
functions for Thg1 family members in mitochondrial metabolism that are not completely 
understood. This mold encodes two mitochondrial Thg1-Like Proteins (TLPs) that catalyze RNA 
modification by incorporating nucleotides in the same 3'-5' direction to distinct tRNA substrates, 
yet it does not encode the highly conserved RNase P in its mitochondria. I hypothesize that 
mitochondrial Thg1 homologs interact with other mitochondrial tRNA processing enzymes to 
catalyze their important functions, and possibly other functions that are distinct from the other 
more well-studied cytosolic functions of these enzymes. To test this hypothesis, I investigated 
the proteins that one of these homologs, DdiTLP2, interacts with during its catalysis of 
mitochondrial tRNAHis (mt-tRNAHis) maturation by using an epitope tag and 
immunoprecipitation. The epitope tagged protein was analyzed in vitro and in vivo, where an 
efficiency defect was discovered in both cases. Additionally, we have optimized a development 
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Introduction 
Throughout biology, we have discovered common themes that exist across all domains of life. 
One such theme is the transfer of genetic information in cells, which is often known as the 
central dogma of molecular biology. In every cell, enzymes work to transcribe DNA to mRNA 
and translate mRNA into proteins. This universal process enables life, as it efficiently and 
precisely synthesizes many proteins that make life possible. At the center of this process lies 
tRNA, the nucleic acid responsible for bringing amino acids to the growing peptide chain. This 
specific step in the central dogma, translation, is unique due to the participation of a separate and 
distinct nucleic acid to bridge RNA and protein sequences. tRNA is often overlooked due to its 
exclusion from the generic explanation of the central dogma (DNA to mRNA to protein), yet its 
role in the cell is extremely nuanced and essential. There are numerous interactions and enzymes 
involved in translation, and incredible specificity is required between all these macromolecules 
for them to work correctly. This specificity can be rooted in a multitude of areas, including 
genetic differences in the nucleic acid sequences that allow them to be distinguished properly 
and post-transcriptional modifications on the nucleic acids. Such specificity allows for tRNA 
recognition by the correct synthetase and subsequent aminoacylation, resulting in the addition of 
amino acids to the growing peptide chain and proteins synthesis1–6. 
This work will focus on tRNA, a molecule that is subject to significant processing prior to its use 
in translation, including being heavily decorated with post-transcriptional modifications7,8. These 
processing events occur all throughout the cloverleaf structure of tRNA, from the 5' end to the 3' 
end, producing a mature tRNA7,8. During tRNA maturation, there are a multitude of processing 
reactions that must occur correctly, including but not limited to: removal of 5' or 3' leaders by 
exo/endonucleases, intron splicing, addition of the 3’ CCA sequence, and tRNA modifications to 
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pseudouridine7–9. Interestingly, one of the RNA processing reactions that has been recently 
described involves an unusual chemistry for nucleotide addition. Even though canonical 
synthesis of all RNAs by transcription occurs in the 5'-3' direction, the discovery that a G-1 
nucleotide can be added to the 5'-end of tRNAHis by the enzyme tRNAHis guanylyltransferase 
(Thg1) revealed that nucleotide addition in the non-canonical (3'-5') direction is also 
possible1,10,11.  
Thg1 was first discovered in the yeast Saccharomyces cerevisiae (yThg1), where it catalyzes the 
addition of a G-1 nucleotide to the 5' end of cytoplasmic tRNA
His (Figure 1B)1,10,11. This non-
templated addition does not follow Watson-Crick base-pairing rules, as the G nucleotide is added 
across from the A73 residue
10,11. The discovery of yThg1 led to further research into this non-
canonical nucleotide addition, revealing the near universally conserved nature of Thg1 in 
eukaryotes12–14. Thg1 has also been discovered in bacteria and archaea, although the enzyme is 
not conserved in these domains12–14. Still, bacteria and archaea encode the G-1 nucleotide in their 
gene for tRNAHis and retain this nucleotide after 5' end processing15,16. In fact, the inclusion of 
the G-1 nucleotide is a universally conserved hallmark of mature tRNA
His across all domains of 
life12. It is required for proper recognition by the cognate histidyl-tRNA synthetase (HisRS) and 
subsequent aminoacylation1–6. Once the yeast gene was identified, searches for homologs in 
other organisms led to the discovery of the Thg1 superfamily of enzymes. This superfamily 
consists of both Thg1 and Thg1-Like Proteins (TLPs), enzymes that are distinct from Thg1 in 
terms of sequence but catalyze a similar 3'-5' nucleotide addition reaction11,17–21. TLPs are also 
different from Thg1 in that they do not have the ability to catalyze non-Watson-Crick addition; 
instead, they prefer to synthesize Watson-Crick base-paired nucleotides with RNA 
substrates14,17,18. These TLPs have been discovered across all domains of life, such as the 
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archaeal species Methanosarcina barkeri, the bacterial species Myxococcus xanthus, and the 
eukaryotic species Dictyostelium discoideum12. TLPs are generally conserved in bacteria and 
archaea, as all bacteria and archaea that have been researched contain one TLP and no Thg110,12–
14. Eukaryotes can contain both a Thg1 and a TLP10,12–14. 
This work will focus on Dictyostelium discoideum (Ddi-) as a model system to investigate the 
functions of its four Thg1 family enzymes, especially the two that are localized to the 
mitochondria. This organism encodes one Thg1 enzyme, DdiThg1, and three Thg1-Like Proteins 
(TLPs), DdiTLP2-413,22. Of the four Thg1 family enzymes, only one has an unknown function22. 
The function of DdiThg1 was readily predicted based on its homology to S. cerevisiae Thg1, and 
its role in the addition of a G-1 nucleotide to cytosolic tRNA
His was previously confirmed13. 
DdiTLP2 was discovered to have a similar role to DdiThg1, but occurring in the mitochondria, 
where it adds a G-1 nucleotide to mitochondrial tRNA
His (mt-tRNAHis)22. DdiTLP3 was found to 
catalyze mitochondrial tRNA editing on the 5' end, acting on many different mt-tRNAs while 
DdiThg1 and DdiTLP2 only act on one specific tRNA13,14,22,23. The function of DdiTLP4 
remains unknown, although its activity has been demonstrated with multiple tRNAs and non-
tRNAs in vitro12,22,24–26. Of these four enzymes, three fourths of them have been found to be 
essential to the survival of the cell, where DdiTLP2 is not essential2,22,27–29. Interestingly, 
DdiTLP2 naturally exhibits an incomplete addition of G-1 to mt-tRNA
His, as its innate efficiency 
only allows for addition of the G-1 nucleotide to 69% of mt-tRNA
His 22. This is distinct from 
DdiThg1, which adds the G-1 nucleotide to all tRNA
His in a cell10,13. In addition, DdiTLP2 has 
been found to be non-essential to the survival as the cell even if it supplements the growth of the 
mold, as a deletion strain of DdiTLP2 has been previously found to only demonstrate a 
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vegetative growth defect with no other phenotypic changes between the DdiTLP2Δ strain and the 
wild type strain22.  
Still, the basic functions of the two D. discoideum mitochondrial TLPs may not be their only role 
within the cell. Mitochondrial TLPs are involved in broader tRNA maturation pathways whose 
players, including the full complex of enzymes that catalyze mitochondrial tRNA 5'-end 
processing, have not yet been fully identified. The complexity of tRNA editing and the many 
intertwined processes suggest that TLPs may interact with other tRNA modification enzymes or 
tRNAs during its catalysis of the G-1 nucleotide addition to tRNA
His (Figure 1B) 7,8. Moreover, 
the mitochondrial phenotypes and consequences of inactivation of mitochondrial Thg1/TLP 
family enzymes have not been completely assessed, despite the fact that vertebrate Thg1 
enzymes are dual-targeted to both cytosol and mitochondria, as verified in humans30–34.  
Therefore, how these enzymes contribute to mitochondrial health and human disease, including 
the possibility of alternative RNA-processing or repair activities catalyzed by these enzymes, is 
not known. 
In this project, we aim to identify candidate proteins for additional mt-tRNA processing activities 
by identifying the proteins that wild-type DdiTLP2 associates with, using an engineered epitope 
tagged DdiTLP2 enzyme that will be expressed in D. discoideum and used to co-
immunoprecipitate interacting proteins. This will be accomplished by cloning, expressing, and 
purifying an epitope tagged DdiTLP2, then analyzing the activity of the tagged enzyme with a 
phosphatase protection assay. If the tag is shown to have no effect on the activity of the enzyme, 
the epitope tagged DdiTLP2 can be expressed into D. discoideum cells, where the proteins 
associated to DdiTLP2 can be identified using the immunoprecipitation approach targeting the 
engineered epitope tag.  
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Chapter 1: Determination of the efficiency of epitope tagged DdiTLP2 in catalysis of G-1 
nucleotide addition to the 5' end of mitochondrial tRNAHis. 
In all organisms, tRNA undergoes extensive maturation processes prior to the addition of an 
amino acid to the growing peptide chain. These processes vary from 5' processing by RNase P, 3' 
processing by endo/exonucleases, splicing of introns, or addition of the conserved 3' CCA 
sequence7–9. Due to the interconnected nature of these processes, it is reasonable to believe that 
the enzymes that catalyze each of these reactions may interact with each other in the cell, such as 
through physical clustering in the nucleolus as observed in eukaryotic cells. Here, we will focus 
on the possible interactions between other tRNA processing enzymes and DdiTLP2. This TLP 
was chosen due to its non-essential role in the cell. Of the three TLPs present in D. discoideum, 
this enzyme is the only one that is not essential to the cell’s survival, as previously confirmed by 
sequencing of the mt-tRNAHis from a deletion strain of DdiTLP222. This deletion strain was 
produced using a blasticidin S-resistance cassette, where a reproducible and statistically 
significant vegetative growth defect was observed22. Total RNA was extracted from these 
DdiTLP2Δ cells, and following circularization of the tRNA, RT-PCR was used to determine that 
there all the mt-tRNAHis were missing the signature G-1 nucleotide that is normally added by 
DdiTLP222. This contrasts with the G-1 observed on 69% of mt-tRNA
His seen in wild type D. 
discoideum22. These two unique features of DdiTLP2, being non-essential to the survival of the 
cell and incomplete addition to the substrate tRNA, has not yet been observed in any other 
enzyme within the Thg1 superfamily14,22. As such, we believe that characterization of DdiTLP2 
is essential to understanding the Thg1 superfamily. In addition, the incomplete addition of G-1 to 
mt-tRNAHis leads us to believe that DdiTLP2 may serve additional purposes in tRNA maturation 
processes. 
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To test this hypothesis, we chose to add an epitope tag to DdiTLP2 for immunoprecipitation. A 
FLAG tag was chosen for this purpose, given its small size (24 nucleotides) and ready 
availability of high quality anti-FLAG antibodies for use in immunoprecipitation procedures35. 
The long-term goal of this work is to isolate the DdiTLP2 from the cell, add a crosslinking 
reagent to covalently link proteins that interact with DdiTLP2, immunoprecipitate the resulting 
conglomeration, and identify any co-purifying proteins using mass spectrometry. I expect that 
this procedure would allow us to identify RNA processing proteins that interact with DdiTLP2, 
as well as possibly to identify other proteins that have not previously been associated with tRNA, 
thus providing insight into other purposes of DdiTLP2 in the cell. Due to the plethora of tRNA 
maturation processes and post-translational modifications in the cell, such an 
immunoprecipitation would provide a framework for us to research these interactions more 
stringently. As the first step toward carrying out this approach, I sought to evaluate the effect of 
the epitope tag on the catalytic efficiency of DdiTLP2, which could adversely affect protein 
folding or post-translational modifications, despite the relatively small size of the FLAG epitope 
sequence.  
Results 
Cloning, expression and purification of C-terminal epitope tagged DdiTLP2  
To test how the presence of an epitope tag affects the activity of DdiTLP2 enzyme, I aimed to 
create DNA constructs that would incorporate a Flag-tag on either N or C termini of the 
DdiTLP2 gene when expressed and purified as a recombinant protein. We were unsure which 
terminal addition would significantly impact enzyme efficiency, so both constructs were 
independently synthesized (Figure 2A). I designed primers for Phusion PCR, which amplifies the 
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wild type DdiTLP2 gene with primers that introduce an additional Flag tag sequence. This gene 
is in the AVA421 plasmid which contains an N terminal His6 tag, ampicillin resistance, and an 
IPTG inducible promoter. The resulting sequence was circularized by ligation for subsequent 
transformation into XL1-Blue cells to recover clones. After restriction screening by EcoRI and 
PstI to identify positive candidates, the addition of a Flag tag onto the DdiTLP2 gene could be 
confirmed by sequencing. After these procedures, addition of the C-term tag was successful, 
while the correct N-term tag was not obtained (Figure 2A). The C-terminal Flag plasmid was 
then transformed into Rosetta pLysS cells which was grown over two days, producing a 1L 
culture. Once the cells in the 1 L culture have reached exponential growth, the tagged protein 
was produced with IPTG overexpression of the lac operon. Following overexpression, the cells 
were lysed using a French Press, the Flag-tagged DdiTLP2 was purified using immobilized metal 
ion chromatography targeting the His6 tag and quantified using a Bradford assay (Figure 2B). 
The final concentration of the protein was 8.44 mg/mL and approximately 900 μL of protein are 
obtained. 
Immunoblotting of the Flag-tagged DdiTLP2 
The resulting protein from purification was then analyzed to confirm the presence and activity of 
a Flag tag. A Western blot was performed for the detection of the epitope tag. We used an anti-
Flag antibody, where the primary and secondary antibodies were conjugated to each other. This 
antibody was generated from a mouse. Through this immunoblotting process, the presence and 
strong activity of the C terminal Flag tag were confirmed (Figure 3 A-C).  
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Determination of the catalytic efficiency of the Flag tagged DdiTLP2 
The activity of the Flag tagged DdiTLP2 was analyzed using an in vitro phosphatase protection 
assay, where the activity of tagged and non-tagged DdiTLP2 enzymes were compared11. In this 
assay, 5’-P32 mt-tRNAHis is reacted with the tagged and non-tagged DdiTLP2 (Figure 4A). The 
reaction is then quenched with RNase A and subsequently treated with a phosphatase, 
specifically CIP. These steps separate 5’ phosphates from the mt-tRNAHis, resulting in separation 
of the 5’ radiolabeled phosphate or a seven-nucleotide fragment containing the radiolabeled 
phosphate. This fragment can only be generated by G-1 addition onto the 5’ end of the mt-
tRNAHis. This assay was run both as an endpoint and as a time course assay. The endpoint assays 
revealed that the wild type DdiTLP2 produced approximately twice the amount of mature mt-
tRNAHis as the Flag tagged DdiTLP2 (Figure 4B). The time course assays revealed an 
approximately 22-fold difference in G-1 addition between tagged and non-tagged DdiTLP2, 
where tagged DdiTLP2 was less active (Figure 4C-E). This was determined using a different 
kinetic method for each enzyme. The wild type DdiTLP2 product formation data was fit well by 
a single exponential rate equation to determine the kobs, so the rate constant for wild type 
DdiTLP2 was determined directly from the equation. The Flag tagged DdiTLP2 could not be 
fitted in this manner, as the observed data points did not follow the single exponential rate 
equation. As a result, the method of linear initial rates was used to calculate the kobs for the 
tagged DdiTLP2. This method uses the linear initial rate and the maximum percentage of product 
formation to calculate the kobs. 
 
11 | P a g e  
 
N-terminal Flag tagged DdiTLP2 does not recover the vegetative growth defect of 
DdiTLP2Δ 
Using Phusion PCR, we were able to obtain a DNA construct with an N-terminal Flag tag on 
DdiTLP2 in a D. discoideum shuttle vector under control of the ACT15 constitutive promoter for 
expression in D. discoideum. This construct was electroporated into the DdiTLP2Δ strain, and 
subsequent cell growth was observed (Figure 5A). A growth curve of the wild type D. 
discoideum, DdiTLP2Δ strain, and of the N-terminal Flag tagged DdiTLP2 strains was obtained, 
and an obvious initial growth defect was observed that is consistent with previous results. 
However, the vegetative growth defect of the DdiTLP2Δ strain was not observed for any of these 
strains; further experiments are required to understand why this growth defect was not 
recapitulated, whether it be changes in the strain after long term storage or slightly different 
growth conditions than those described previously. One possible reason for the inability of the 
epitope tagged DdiTLP2 to completely complement the growth defect could be because of low 
expression of this protein, possibly caused by the presence of the FLAG epitope. Thus, we also 
wanted to measure the expression of this Flag tagged DdiTLP2. This was done with a Western 
blot, where expression of the enzyme was confirmed (Figure 5B-D). 
Discussion 
In this chapter, I described how I was able to construct and test one of the two DdiTLP2 epitope 
tagged proteins that is needed to carry out the immunoprecipitation experiment to identify 
interacting proteins.  Construction of the epitope tagged DdiTLP2 began with slight difficulties 
in the mutagenic PCR protocol. Phusion PCR was chosen due to its ability to add short 
fragments into an existing DNA plasmid. This is ideal for the addition of a Flag tag, as its 
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sequence is only 24 nucleotides long and could be designed to contain enough G and C residues 
to ensure optimal primer design35. This cloning strategy was successful for the addition of the 
Flag tag onto the C terminus of the DdiTLP2. Still, we were unable to generate a DdiTLP2 with 
the Flag tag on the N terminus. As can be seen from the agarose gel following PCR (Figure 2A), 
a DNA fragment with the expected size was generated from both PCR reactions. Since the 
expected band did appear on the gel, the ligation reactions were carried out, and the resulting 
DNA was transformed into competent cells and growth was observed on ampicillin plates. 
However, the resulting DNA from these cells never contained the desired N terminal epitope 
tagged DdiTLP2, as confirmed by sequencing. Subsequent gel extractions and altered primer 
annealing temperatures were also unsuccessful, as any strain that produced viable bacteria 
following ligation and transformation did not contain the correct sequence, again confirmed by 
sequencing results. Future studies involving in vivo assays will further analyze N terminal Flag 
tagged DdiTLP2, since these in vitro methods were ultimately unsuccessful. Future studies will 
also require an alternative method for generating this DNA construct, leading to a more complete 
picture of DdiTLP2. 
Following these cloning procedures, the C-terminal Flag tagged DdiTLP2 was purified. The C 
terminal Flag tagged DdiTLP2 gene was transformed into Rosetta pLysS cells, where the T7 
promoter controlling expression of DdiTLP2 was induced using IPTG. The resulting protein was 
purified using an immobilized metal ion affinity chromatography (Figure 2B). To confirm that 
the purified protein contained the FLAG epitope that was introduced by mutagenesis, a Western 
blot was performed. Even as we intentionally placed the tag on the terminus of the peptide 
sequence, there was a chance that the folded conformation adopted by the protein could result in 
degradation of the protein, which could lead to loss of the epitope tag. However, the western blot 
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confirms that the tag is present in very high amounts (Figure 3C). This will be helpful for future 
immunoprecipitations, as the presence of the Flag tag allows for immunoprecipitation of 
DdiTLP2.  
The purification of the epitope-tagged protein allowed us to continue and test the activity of the 
DdiTLP2 enzyme that contains this additional sequence. It was important to confirm that the tag 
did not significantly interfere with the activity of the enzyme, as a significant reduction in 
activity would mean that the possible interactions of the enzyme and other proteins would also 
be affected, resulting in an inaccurate immunoprecipitation. The activity decrease could have 
induced an increase or decrease in protein-protein interactions, so we would want to see the same 
activity in our Flag tagged DdiTLP2 as in wild type DdiTLP2. This led us to the phosphatase 
protection assay, a common method used in our laboratory to assess the activity of Thg1 and 
TLPs11. The resulting efficiency difference between the Flag tagged DdiTLP2 and wild type 
DdiTLP2 led us to a difficult decision. While a 22-fold decrease in rate associated with presence 
of the epitope tag could not be ignored, it was small enough for us to consider moving forward 
with the project. Although this is not known for TLP2, it is possible that even a sub-optimally 
active protein could still fulfill the biological function of the wild-type protein. This is due to the 
safeguards that are present in a typical cell that can sometimes buffer the cell from detrimental 
changes in protein expression. In a cell, some proteins are produced in excess, as the production 
of exact stoichiometric quantities would harm the cell should the production of that protein be 
affected. In addition, there are many post-translational modifications in vivo that cannot be 
replicated in vitro. It is possible that the presence of native modifications on the FLAG-tagged 
DdiTLP2 could help to compensate for the decreased activity of the enzyme, again leading to 
sufficient levels of activity in vivo.  
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To assess whether either of these mechanisms might be possible for DdiTLP2, we reasoned that 
if the growth defect of DdiTLP2 can be recovered by transforming Flag tagged DdiTLP2 into the 
DdiTLP2Δ strain, then the epitope-tagged protein could be used for IP experiments. To fully 
assess whether the tagged TLP2 recovers wild-type function, we would need to perform analysis 
of total RNA in cells expressing this protein and determine how much G-1 has been added to the 
mt-tRNAHis.  If this number is not different statistically compared to the 69% previously 
observed in wild type D. discoideum, we would confirm that the C-terminal epitope tagged 
DdiTLP2 can be used in place of the wild-type protein to identify functional protein 
interactions22. Unfortunately, although the recombinant data were obtained for the C-terminally 
tagged protein, we were not able to obtain an equivalent C-terminal FLAG-tagged construct for 
expression in D. discoideum, due to similar cloning issues encountered earlier. However, we 
were able to obtain an N-terminal Flag tagged DdiTLP2 in the vector for expression in D. 
discoideum and decided to move forward with the growth complementation experiments, despite 
the mismatch in proteins being studied with each approach. As described before, if either of the 
tagged enzymes was able to revert the vegetative growth defect of the deletion strain, we would 
consider this evidence of the protein's function and appropriateness for use in the 
immunoprecipitation approach.  
Unfortunately, this was not the case for N-terminal Flag tagged DdiTLP2. While we were never 
able to analyze the efficiency of this enzyme in vitro, the initial growth defect observed for the 
DdiTLP2Δ strain and the N-terminal Flag tagged DdiTLP2 indicate that there may also be 
problems with introducing a Flag epitope at this location of the protein. The western blot 
confirmed that the enzyme was expressed, so this could not have been the issue that led to an 
inability to complement the growth defect (Figure 5C). Still, of the two tested positions, we 
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consider it more likely that the N-terminal of the DdiTLP2 peptide sequence is not an optimal 
location to place the tag on. This tag sits inside of a mitochondrial targeting sequence on the N 
terminus, which is used to target this protein to the mitochondria and then is cleaved after protein 
import. The presence of this additional sequence at this location may interfere with protein 
folding or import and therefore be more likely to create a non-functional protein. This possible 
interference would be avoided on the C terminus. We hope that this bodes well for the recovery 
of the vegetative growth defect once we are able to obtain the necessary construct for C-terminal 
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Chapter 2: Characterization of the development of D. discoideum using a development 
assay 
As our knowledge about stem cells has increased, D. discoideum has been coined as “nature’s 
stem cell.” This status stems from the mold’s ability to change form and aggregate as it is 
deprived of nutrients36,37. This aggregation and subsequent development cycle have been well 
established (Figure 6A)36,37. This mold begins as a single, vegetative amoebae that matures into a 
multicellular fruiting body36,37. Aggregation is induced by depriving the cells of nutrients, such 
as plating the cells onto plates composed of agar and a salt. The aggregation is mediated by a 
chemotaxis of cells towards a secreted cAMP signal, forming mounds36. These mounds will 
continue to aggregate and grow higher, such that eventually the mounds will fall over. The cells 
now form a slug structure, the next point in development. Aggregation will then continue in a 
similar fashion, where the cells will aggregate at one end point of the slug. Such an aggregation 
describes a culminant or Mexican hat, where there is a complete accumulation of cells at one end 
of the slug but a lack of verticality. If the cells do achieve verticality, where the cells have 
differentiated into stalk cells that support a spore head, the cells are in the fruiting body phase. 
For this work, the fruiting body will be considered the end of development. In the life cycle of D. 
discoideum, fruiting bodies will sporulate and produce more spores to restart the development 
cycle36. However, these spores are not observable at the same zoom as the aggregated structures, 
so they will not be considered here.  
Interestingly, the development of the DdiTLP2Δ strain has not been described in any of our lab's 
previous work. Instead, the growth of the DdiTLP2Δ has been described, where the vegetative 
growth defect was observed. There was no morphological difference observed in the single cells 
when observed under a microscope, where the wild type AX2 cells and the DdiTLP2Δ both had 
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a circular shape and translucent appearance. The use of a development assay would provide a 
more complete picture of the growth of the DdiTLP2Δ strain. Here, I report on my comparison 
of the development of wild type D. discoideum and DdiTLP2Δ cells using a development assay. 
Results 
Optimization of the D. discoideum development assay 
The development of D. discoideum has been well described and photographed using higher 
concentrations of cells grown over a short period of time36. However, due to the vegetative 
growth defect of the DdiTLP2Δ strain, we aimed to develop a new protocol where cells could be 
more readily compared, despite the slower growth phenotype associated with the TLP2Δ strain. 
We used the same buffers and plates as previously described, where the cells are washed in 
buffer to remove nutrients and plated on nutrient poor KK2 plates which are composed of agar 
and a salt. Still, the concentrations and growth times for these concentrations needed to be 
optimized. Concentrations ranging from 1 million to 5 million cells per 10 cm petri dish grown 
over one week provided the most useful data after development was complete. All four of the 
previously described structures in development – slugs, mounds, culminants, and fruiting bodies 
– were counted at various time points throughout the development assay. At each point, the 
plates were photographed under a microscope and a representative counting area was chosen for 
each image. This was done to reduce the counting burden for the assay and to ensure that we 
could see if any fruiting sprouted from outside the counting area but had a spore head inside the 
counting area. A 3 mm by 3 mm square was used as this counting area. Structures in each 
counting area were categorized into one of these four groups, and the percentage of structures in 
each stage was calculated. After one week of growth, there were no more significant changes to 
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these percentages. Any spores that were produced by either the wild type or DdiTLP2Δ strains 
following fruiting body formation were either unable to form mounds or formed mounds that 
were too small to be observed at the chosen magnification.  
DdiTLP2Δ exhibits a developmental growth defect 
In previous work, the DdiTLP2Δ strain was only found to have a vegetative growth defect that 
results in a slightly slower doubling time when grown in liquid media22. To test the same 
DdiTLP2Δ cells for their ability to undergo development, cultures were grown first in liquid 
media to obtain a sufficient cell count, and then on plates for development (Figure 6B, C). At the 
optimized concentrations of cells described above, the DdiTLP2Δ strain demonstrated a 
statistically significant developmental growth defect (Figure 6D). A significantly higher 
percentage of wild type cells reached the fruiting body stage, the largest structure that can be 
seen and the designated end point for the development assay. The DdiTLP2Δ strain had a 
significantly higher percentage of cells at each of the earlier development stages, except for 
mounds. At higher concentrations, the DdiTLP2Δ did demonstrate a small developmental defect, 
although it was not statistically significant. This defect may prove statistically significant over a 
larger sample size, but at the size seen in this experiment it was not significant.   
Discussion 
The development assay for D. discoideum has been well described in the past but has not been 
used to study the DdiTLP2Δ strain that was the focus of this work. These previous assays have 
utilized approximately 10 million cells per 10 cm Petri dish, where the cells will undergo rapid 
development, completing the entire process in 24-48 hours36. This did not allow for a sufficiently 
sensitive development assay to detect smaller differences between wild type vs. mutant cells that 
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might only be visible at certain times during the process, as access to a microscope was limited at 
odd hours of the day. Furthermore, the vegetative growth defect of the DdiTLP2Δ strain did not 
allow for this large number of cells to be easily grown. As a result, we chose to decrease the 
number of plated cells used to start the assays. We believed that this modification would allow us 
to photograph the cells throughout their development, ensuring that we would capture the cells at 
the moment development was complete, and at multiple stages in between.  
The decreased initial cell counts also affected the aggregation of the cells. As there were less 
cells on the plate, we reasoned that the cells would develop slower than in the previously 
described development assays. We believed that with fewer cells on the plate, the time required 
for chemotaxis would increase and slow the development cycle. This suspicion was confirmed, 
as plates with 1-5 million cells finished development over 7 days. The lower cell counts 
described here would be useful in future development assays, as the longer development time 
and decreased aggregation allowed us to obtain a more rigorous development assay. We would 
also be able to document the growth of D. discoideum throughout the development cycle, 
although these data may not be as important as the endpoint data. This is because we were most 
interested in the percentage of cells that reached each developmental stage.  
The other main difference between plates with higher cell counts and those with lower counts 
was the size of the structures that were observed. On plates with higher counts, the structures 
observed were much bigger in size, resulting in more subjective counting. In many cases, the 
structures on these plates extended past the edge of the chosen counting area, regardless of the 
specific part of the image. It was difficult to discern which structures to count and which to 
ignore, as we only wanted to count those which were in a set area for standardization. This was 
especially difficult for fruiting bodies, as the stalk would often extend through half of the 
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designated counting area. It was also difficult to ensure that all structures in each area were 
counted, as fruiting body stalks would overlap inside the counting area. It was then hard to 
discern slugs from fruiting bodies, and if a fruiting body sprouted from inside the counting area 
or not. Interesting, a similar number of structures were observed on plates with lower cell counts, 
yet the structures were much smaller. We had expected to observe a smaller number of structures 
due to the lower cell count, but it seems that the greater distance between cells only affected the 
size of the structures. This difference greatly aided the standardization of the counting protocol. 
It was easier to maintain accuracy and precision when counting these structures, as very few of 
them extended far into or out of the counting area. The structures also were separated in the 
counting area, such that there was little overlap between structures. This helped to ensure that all 
structures inside the counting area were accounted for. 
Using this optimized development assay procedure, the development of wild type D. discoideum 
and the DdiTLP2Δ strain were compared. The development of DdiTLP2Δ had not been 
previously described, although there is a replicable and statistically significant vegetative growth 
defect observed for the DdiTLP2Δ when compared to wild type D. discoideum. This was the 
only difference observed between the two strains, as other previous qualitative assessments of 
DdiTLP2Δ had been inconclusive. Cells from either strain looked the same under a microscope, 
both in shape and translucence. The vegetative growth defect suggested that there may also be a 
development defect, and this was confirmed by the development assay. This defect was only 
statistically significant at lower concentrations, as the defect was still present at higher 
concentrations but was not statistically significant.  
It is unclear why this defect is only significant at lower concentrations. There is no difference in 
growth rate when the cells are at high concentration or at low concentration when grown in 
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media. As such, it is somewhat puzzling that there is a developmental defect associated with 
DdiTLP2Δ that can be readily observed at low concentrations but no such defect at high 
concentrations. This may be because of the aggregation in development. The larger structures 
and shorter chemotaxis distances that are present at high concentrations may help the DdiTLP2Δ 
strain recover some aspect of development, as the high concentration of cells may overcome the 
defect observed at lower concentrations. The lack of statistical significance may also be the 
result of experimental error, as the larger structures formed at these concentrations may have 
obscured additional structures in the counting area. There may have also been a more significant 
defect earlier in development, as only the endpoint of the assay was able to be analyzed under 
these conditions, due to the rapid time frame for development to occur.  
The developmental defect for the DdiTLP2Δ strain seen at lower concentrations is likely rooted 
in the same reason that there was a vegetative growth defect when grown in rich liquid media. 
The DdiTLP2Δ cells are proven to grow slower than wild type cells, so this defect was also 
expected to be observed in development. Still, this is the only difference between the wild type 
cells and the DdiTLP2Δ cells. As can be seen in Figures 6B and C, there is no clear qualitative 
difference between the two – each structure in each stage of development looks similar for each 
strain. This result provides additional insight to the role of DdiTLP2 inside the cell. It has been 
previously confirmed that the G-1 addition to mt-tRNA
His is not strictly essential, suggesting that 
the HisRS in the mitochondria of D. discoideum is able to aminoacylate enough mt-tRNAHis over 
time to produce a viable cell. The growth and development defect demonstrated by DdiTLP2Δ 
may be related to less efficient aminoacylation or may be due to another effect of DdTLP2 
entirely. It would be interesting for future studies to focus on the role of the mitochondrial 
HisRS, analyzing the specific region of the mt-tRNAHis that it recognizes prior to 
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aminoacylation. Specifically, the binding region should be compared between mt-tRNAHis that 
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Conclusion and Future Studies 
Canonical DNA and RNA biosynthesis is restricted to propagating nucleic acid synthesis in the 
5’ to 3’ direction. However, the discovery that a G-1 nucleotide can be added to the 5’-end of 
tRNAHis by the enzyme Thg1 revealed that nucleotide addition in the opposite (3'-5') direction is 
also possible. Further research into Thg1 revealed the Thg1 superfamily of enzymes that are all 
capable of this 3’-5’ nucleotide addition. One organism in particular, D. discoideum, contains a 
Thg1 enzyme and 3 TLPs. This work focused on characterizing one of these TLPs, DdiTLP2, 
using immunoprecipitation. A Flag tag was added to DdiTLP2 for these immunoprecipitations, 
and the activity of these enzymes was assessed. The best terminus for addition of this tag was 
unknown, so addition of the tag to each terminus was attempted. Only C-terminal Flag tagged 
DdiTLP2 was successfully synthesized and purified for in vitro analysis, and the presence of the 
Flag tag was confirmed using a western blot. To determine the activity of the enzyme, a 
phosphatase protection assay was completed, where a 22-fold defect in activity for C-terminal 
Flag tagged DdiTLP2 was observed when compared to wild type DdiTLP2. For in vivo analysis, 
only N-terminal Flag tagged DdiTLP2 was successfully cloned. It was subsequently 
electroporated into the DdiTLP2Δ strain, where expression of this protein was observed but the 
vegetative growth defect was not recovered. This suggests that the addition of an epitope tag 
onto this terminal end of the protein results in a significant activity defect that is not overcome 
by excess protein in the cell. The development of wild type D. discoideum and the DdiTLP2Δ 
strain were also characterized, where a statistically significant developmental defect was 
observed for DdiTLP2Δ.  
Future studies into Flag tagged DdiTLP2 should focus on synthesizing C-terminal Flag tagged 
DdiTLP2 for in vivo studies. Since we have learned that N-terminal Flag tagged DdiTLP2 is not 
24 | P a g e  
 
sufficiently effective in the cell, it would be unnecessary to complete in vitro studies on this 
enzyme at this point. Preliminary work into the synthesis of C-terminal Flag tagged DdiTLP2 
has led to a restriction cloning protocol that shows promise for generating the correct sequence. 
If this cloning is successful, a growth curve, development assay, and western blot should be 
completed for determine the efficiency of the epitope tagged enzyme in vivo. If the vegetative 
growth defect is recovered with the C-terminal Flag tagged DdiTLP2, the enzyme should be 
crosslinked and immunoprecipitated to determine if any proteins are interacting with DdiTLP2 
during the catalysis of G-1 addition. The success of the tagging procedure would also lead to a 
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Materials and Methods 
C-Terminal Flag Tagged DdiTLP2 Expression and Purification 
In previous work in our laboratory, the DdiTLP2 gene was cloned into an AVA-421 plasmid. 
This plasmid contains an ampicillin resistance gene, an N-terminal His6 tag, and an IPTG 
inducible promoter for overexpression. Using this gene from our lab, Phusion PCR was used to 
add a C terminal Flag tag amplify the resulting gene. Following restriction digests by EcoRI and 
PstI to provide an initial confirmation of the sequence, the genes were sent to DNA sequencing 
to confirm addition of the C terminal Flag tag. The resulting gene was transformed into Rosetta 
pLysS cells, which is a strain of E. coli designed for protein expression. IPTG was used to induce 
overexpression in these cells, and the protein was purified using an immobilized metal ion 
affinity chromatography. The protein size and purity were confirmed using an SDS-PAGE gel. 
The concentration of the purified protein was determined using a Bradford assay.  
Western Blot 
To confirm the activity of the Flag tag on the C-terminal of DdiTLP2 or to confirm the 
expression of N-terminal Flag tag DdiTLP2 in D. discoideum, we utilized western blots. For this, 
a titration of the protein of interest, control proteins for the Flag tag, and ladders were ran on an 
SDS-PAGE gel. These proteins were then transferred to a nitrocellulose membrane by 
electrophoresis. The buffer in this electrophoresis was composed of 28.80 g of Tris base and 6.04 
g of glycine dissolved in 1.8 L of water and 0.2 L of methanol. This transfer membrane was 
visualized using an Ponceau stain, where all proteins on the membrane can be seen. After 
removing the stain, the membrane is shaken in 4% nonfat milk for at least 3 hours. The primary 
antibody is then added to the new milk and shaken for at least 3 hours. The same is done for the 
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secondary antibody. The antibodies are then visualized using an ECL kit. The membrane is 
exposed to film, where the exposure time varies depending on activity of the antibodies. 
Phosphatase Protection Assay 
In previous work, the phosphatase protection assay has been developed to determine the 
efficiency of Thg1 and TLP nucleotide addition to tRNAHis 11,23. Two different types of this assay 
were completed in this work, endpoint assays and time course assays. For the endpoint assays, a 
titration of the DdiTLP2 enzyme was added to 5'-32P labeled mt-tRNAHis missing the G-1 
nucleotide. The reaction is quenched after 2 hours by addition of RNase A. A phosphatase 
originating in cows (CIP) is then used to remove the 5' phosphate on each mt-tRNAHis. The 
products are resolved on a silica TLC overnight in a 55:35:10 (v:v:v; n-propanol:NH4OH:H2O) 
solvent system. These TLC plates were visualized by a Typhoon Trio phosphorimager and 
quantified using ImageQuant. The time course assays were completed similarly to the endpoint 
assays, except a constant concentration of DdiTLP2 was used and the reaction was quenched at 
set time points in the reaction. The time courses of product formation were plotted and fit to a 
single exponential rate equation in Kaleidagraph (Synergy Software). For time courses that did 
not fit this equation, the method of linear initial rates was used38. 
Growth of D. discoideum 
In previous work in our laboratory, D. discoideum was frozen in the -80 °C freezer for long term 
storage. These cells are frozen in a solution of HL5 media with no antibiotics and DMSO in a 9:1 
ratio36,39. For growth, the cells are quickly thawed in a warm water bath until a small amount of 
ice remains and subsequently added to a 10 cm petri dish containing 10 mL of HL5 media36,39. 
After the cells are allowed to recover at room temperature for 1 hour, they are centrifuged at  
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500 xg for 10 minutes at 4 °C36,39. A new 10 mL of HL5 media is then used to resuspend the cells 
for growth at 21 °C, the temperature for all subsequent growth. This process of centrifugation 
and resuspension in new media is used any time the media needs to be changed. Following this 
first night of growth, the media is changed into HL5 media containing ampicillin and 
streptomycin. From this point forward, the growth of the D. discoideum cells is checked daily. 
The cells are counted using a hemacytometer, where they are diluted as necessary to ease the 
counting burden. This is done to ensure that the concentration of cells is always between 5 x 104 
and 4 x 106 cells/mL. If the cells have grown to the top of this range, they are pelleted and 
resuspended using the previous protocol, and a fraction of the resuspended pellet is used. The 
fraction is calculated such that the new concentration is always 5 x 104 cells/mL. 
Electroporation of D. discoideum 
The typical transformation processes used for E. coli are not effective for D. discoideum; as a 
result, electroporation is used for transformations in this system39. For electroporation, 
electrocompetent cells must be prepared from our strains of interest. These cells are harvested, 
centrifuged at 500x g for 10 minutes at 4 °C, then resuspended with a Na3PO4 buffer. The cells 
are then centrifuged again at the same speed and resuspended in ice cold HL50 buffer to a final 
concentration of 1 x 107 cells/mL. The cells are now electrocompetent. 10 μg of the DNA to be 
transformed is then added to 700 μL of these cells in a sterile 4 mm electroporation cuvette on 
ice. Using a Biorad X cell gene pulser, the cells are electroporated using the preset Dictyostelium 
settings (V = 1.0 kV, 10 μF, 1.0 ms pulse length, two pulses, 5-s pulse interval). The 
electroporated cells are then quickly added to 1 mL of HL5 media in a petri dish and shaken at 
40 RPM for 15 minutes at room temperature. Cold solutions of CaCl2 and MgCl2 are then added 
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to final concentrations of 2 mM each, and the dish is again shaken at 40 RPM for 15 minutes at 
room temperature. The resulting cells are added to 11 mL of HL5 media for growth overnight at 
21 °C. The media is changed the next day to 10 mL of HL5 media with ampicillin and 
streptomycin. 
Development Assay of D. discoideum 
To assess the development of D. discoideum, previously described development assays were 
used to optimize the assay for DdiTLP2Δ36. For this assay, 2 x 107 cells were grown for 
subsequent plating. These cells were grown according to the procedures described above. After 
determining the number of cells grown, the cells were pelleted and resuspended in 10 mL of DB 
buffer. This solution was then split such that 4 tubes were generated. The tubes contained 1 x 
107, 5 x 106, 2.5 x 106, and 1 x 106 cells, respectively. These tubes were all centrifuged and 
resuspended in 3 mL of DB buffer twice. After the second resuspension, the cells are centrifuged 
again and resuspended in 200 μL of DB buffer. This solution is plated onto a nutrient poor KK2 
plate and spread evenly with a sterile glass spreader. The plate is wrapped in a wet paper towel 
and placed in a resealable zipper storage bag for development at 21 °C. The cells are allowed to 
develop for 7 days, after which they are photographed using an Olympus SZX16 microscope. Six 
pictures of each plate are taken. Due to software issues with this microscope – the scale bar did 
not change with the zoom of the microscope – all plates were photographed using the same 
settings to ensure the scale bar was standardized. The bottom light was set to max brightness, an 
additional LED lamp was set to 1.3, the exposure was set to 1/200 second, the objective used was 
1.25x, the sensitivity was ISO 200, and the zoom was set to 1.6x. A 3 x 3 mm square is used for 
counting the structures on each picture to reduce the counting burden. 
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Lysing of D. discoideum cells 
For Western blotting and immunoprecipitations, the D. discoideum cells are lysed by sheer force 
using a steel ball cell cracker40. The balls used here are 8.002 mm in diameter. After counting the 
cells, they are pelleted and resuspended in 1 mL of cell cracker buffer. This is done to maximize 
the concentration of the solution when passed through the cell cracker. A 5 mL syringe is used to 
draw up this solution and it is passed through the cell cracker 10-15 times. Intact cells are then 

























Figure 1: Phylogeny of Thg1 Superfamily (A) A phylogenetic analysis of the Thg1 
superfamily showing Thg1 and DdiTLP phylogeny. Thg1 is shown to contain similarities across 
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Figure 2: Cloning and Purification of C-terminal Flag DdiTLP2 (A) A 1% agarose gel after 
Phusion PCR of N and C terminal Flag DdiTLP2. Lanes 2 and 3 contain N-terminal Flag 
DdiTLP2 and C-terminal Flag DdiTLP2, respectively, where the expected band is outlined in the 
green box. Lanes 4 and 5 contain no template DNA, where N-terminal primers were used in lane 
4 and C-terminal primers were used in lane 5. Lane 6 contains no primers. (B) An SDS-PAGE 
gel after purification of C-terminal Flag DdiTLP2, where the expected size was 32 kD. Lanes 2-
10 include: pre-induction sample, post-induction sample, pre-lysis, crude extract, flow through, 
wash 1, wash 2, purified C-terminal DdiTLP2, TALON resin. 
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Figure 3: Western Blot of C terminal Flag DdiTLP2 (A) The Coomassie stained SDS-PAGE 
gel following protein transfer to the membrane. (B) The Ponceau stained nitrocellulose 
membrane following transfer of proteins. (C) The exposure pattern of the interaction between 
anti-Flag-HRP and C terminal Flag DdiTLP2. Lane 2 is a positive control of yTrm10 Flag that 
did not show up. Lane 3 is a negative control of wild type DdiTLP2. Lanes 4-7 are a titration in 
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Substrate Enzyme kobs (min-1) 
Ddi mt-tRNAHis G+1 
DdiTLP2 0.099 ± 0.007 




DdiTLP2 data fit to single exponential 
DdiTLP2 FLAG analyzed with method of linear initial rates 
[E] = 3 µM final concentration, [E] > [S] 
Figure 4: Phosphatase Protection Assay of C term Flag DdiTLP2 (A) A schematic for the 
phosphatase protection assay. DdiTLP2 adds a G-1 nucleotide to the 5’ end of Ddi mt-
tRNAHisGUG, protecting the 
32P G+1 nucleotide. The reaction is then quenched by RNase A 
followed by phosphatase digestion removing the 5’ phosphate group. The products are then 
resolved by silica TLC. (B) A representative TLC scan of an endpoint assay of DdiTLP2 activity 
on mt-tRNAHis after RNase A digestion. Spots correlating to G-1 addition and unreacted 
phosphate are labeled. The activity of the enzyme is confirmed by the disappearance of the G-1 
spot with removal of DdiTLP2. (C) A representative TLC scan of a time course assay of 
DdiTLP2 activity on mt-tRNAHis after RNase A digestion. The activity of the enzyme is 
confirmed by the appearance of the G-1 spot over time. (D) The time courses from (C) are plotted 
here, where formation of the G-1 product is plotted against time. (E) The data from DdiTLP2 fits 
a single exponential, and the kobs was taken directly from this. The method of linear initial rates 
was used to calculate the kobs for FLAG tagged DdiTLP2. A 22-fold defect in activity for FLAG 
















Figure 5: Western Blot of N-terminal Flag DdiTLP2 (A) The workflow of the in vivo analysis 
of N-terminal Flag DdiTLP2. (B) The Coomassie stained SDS-PAGE gel following protein 
transfer to the membrane. (C) The Ponceau stained nitrocellulose membrane following transfer 
of proteins. (D) The exposure pattern of the interaction between anti-Flag-HRP and N-terminal 
Flag DdiTLP2. Lane 2 is a negative control wild type DdiTLP2. Lane 3 is a positive control of 
C-terminal Flag DdiTLP2. Lanes 4-7 are an increasing titration in concentration of cell extract 
from cells containing N-terminal Flag DdiTLP2. Lane 8 contains uncracked cells containing N-
terminal Flag DdiTLP2. 
 


























































































































































Figure 6: Development of Assay of D. discoideum and the DdiTLP2Δ strain. 
(A) Representative images for each stage in development counted in the development assay. 
Picture is used with permission from M.J. Grimson and R.L. Blanton from Texas Tech 
University. (B) A representative microscope image of the development assay after 1 week of 
growth. There were 5 x 106 AX2 cells plated on this plate. The 3 mm by 3 mm square was used 
for counting. (C) A representative microscope image of the development assay after 1 week of 
growth. There were 5 x 106 DdiTLP2Δ cells plated on this plate. The 3 mm by 3 mm square was 
used for counting. (D) The percentage of cells on each plate that reached each major 
developmental stage. The data is split by cell type and number of cells on the plate. Significant 
developmental defects are seen at 2.5 x 106 and 1 x 106 cells, where wild type AX2 cells reach 
later developmental stages faster than DdiTLP2Δ cells. The asterisks indicate statistical 
significance from a chi squared test. 
D 
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